Zoledronate-induced remission of acute panmyelosis with myelofibrosis

Eur J Haematol. 2004 Sep;73(3):215-8. doi: 10.1111/j.1600-0609.2004.00277.x.

Abstract

Acute panmyelosis with myelofibrosis is a rare and aggressive form of acute myeloid leukemia. We describe a new case with a huge proliferation of megakaryocytes, blast cells and reticulin fibers. The patient was treated with zoledronate, a third-generation bisphosphonate, and a gradual recovery from pancytopenia was observed. A new bone marrow biopsy performed 4 months later showed a surprising disappearance of the leukemic infiltration. Ten months after the diagnosis, the patient is still in healthy condition. This may support the recently described anti-tumor activity of zoledronate.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aged
  • Blood Cell Count
  • Blood Transfusion
  • Bone Marrow Examination
  • Diphosphonates / therapeutic use*
  • Humans
  • Imidazoles / therapeutic use*
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / pathology*
  • Male
  • Primary Myelofibrosis / drug therapy*
  • Remission Induction / methods
  • Zoledronic Acid

Substances

  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid